What's Happening?
The latest episode of 'This Week In Space' podcast discusses the significant research conducted aboard the International Space Station (ISS) as it approaches its planned deorbit in 2030. Hosted by Rod Pyle and Tariq Malik, with guest Lynn Harper from NASA Ames Space Portal, the episode highlights the ISS's contributions to cancer treatment research, the development of replacement retinas, and potential Alzheimer's disease breakthroughs. The ISS, a $150 billion investment, has served as a pivotal research hub for over 25 years, raising questions about the future of space-based research as its operational life nears its end.
AD
Why It's Important?
The ISS has been a cornerstone of international collaboration and scientific advancement in space. Its research has led to significant medical and technological breakthroughs that could have profound impacts on healthcare and industry. The potential end of the ISS's mission raises concerns about the continuity of space-based research and the loss of a unique platform for scientific experimentation. The discussion underscores the importance of evaluating the ISS's legacy and considering future investments in space research infrastructure to maintain momentum in scientific discovery.
What's Next?
As the ISS's deorbit approaches, discussions about its replacement or the development of new space research platforms are likely to intensify. Stakeholders, including NASA and international partners, will need to decide on the future of space-based research and the potential for new collaborations. The transition period may involve exploring alternative platforms or extending the ISS's operational life to ensure continued access to space for scientific research.
